Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2017 Feb 10;154(2):620–628.e6. doi: 10.1016/j.jtcvs.2017.01.050

Table 1. Observed and Predicted Mortality and New Functional Morbidity in RACHS and STAT Categories.

Both observed and predicted mortality and functional morbidity rates increased with increasing severity categories for both systems (both p < 0.0001 Predicted new functional morbidity rates also increased with increasing severity categories (RACHS: p=0.0032; STAT: p=0.0009).

RACHS N Median Age
(Months)
Crude Mortality
N (%)
Predicted Mortality
N (%)
Mortality
SMR (95% CI)
Crude New Morbidity
N (%)
Predicted Morbidity
N (%)
Morbidity
SMR (95% CI)
1 114 55  0 (0.0%)  0.7 (0.6%)  0 (NA-5.3)  2 (1.8%)  2.9 (2.5%)  0.7 (0.1–2.5)
2 585 6 10 (1.7%)  9.2 (1.6%) 1.1 (0.5–2.0) 15 (2.6%) 21.7 (3.7%) 0.7 (0.4–1.1)
3 517 9 17 (3.3%) 16.2 (3.1%) 1.1 (0.6–1.7) 24 (4.6%) 24.1 (4.7%) 1.0 (0.6–1.5)
4 149 0  8 (5.4%) 11.5 (7.7%) 0.7 (0.3–1.4) 15 (10.1%) 10.5 (7.1%) 1.4 (0.8–2.4)
5 3 0  0 (0.0%) 0.3 (11.2%)  0 (NA-10.9)  0 (0.0%) 0.3 (9.7%) 0 (NA-12.2)
6 79 0 9 (11.4%) 10.4 (13.1%) 0.9 (0.4–1.7) 11 (13.9%) 7.7 (9.7%) 1.4 (0.7–2.6)
Unable to classify 103 69 6 (5.8%) 1.5 (1.5%) 3.9 (1.4–8.5) 7 (6.8%) 3.8 (3.7%) 1.9 (0.7–3.8)
STAT
1 423 28 2 (0.5%) 3.8 (0.9%) 0.5 (0.1–1.9) 7 (1.7%) 12.7 (3.0%) 0.5 (0.2–1.1)
2 513 15 10 (1.9%) 8.2 (1.6%) 1.2 (0.6–2.2) 11 (2.1%) 18.5 (3.6%) 0.6 (0.3–1.1)
3 205 5 6 (2.9%) 6 (2.9%) 1.0 (0.4–2.2) 11 (5.4%) 9.7 (4.7%) 1.1 (0.6–2.0)
4 308 0 21 (6.8%) 20.6 (6.7%) 1.0 (0.6–1.6) 31 (10.1%) 21.1 (6.9%) 1.5 (0.99–2.1)
5 85 0 9 (10.6%) 10.7 (12.6%) 0.8 (0.4–1.6) 11 (12.9%) 8.1 (9.5%) 1.4 (0.7–2.4)
Unable to classify 16 40 2 (12.5%) 0.5 (2.8%) 4.4 (0.5–15.8) 3 (18.8%) 0.8 (5.2%) 3.6 (0.7–10.6)

Abbreviations: SMR = Standardized Morbidity/Mortality Ratio